De Filippis S

Neuropsychiatric Clinic Villa Von Siebenthal, Genzano di Roma , ,

8 papers

ArticleKetamine

ECHO: Results from a Non-Interventional Cohort Study of Esketamine Nasal Spray in Treatment Resistant Depression

Rosso G, Constant E, De Filippis S +12

Europe PMC2026
ArticleKetamine

Esketamine in Treatment Resistant Depression: Acute Effects on Dissociation and Therapeutic Effects at the End of the Induction Period

Lombardozzi G, Kotzalidis G, Trovini G +5

Europe PMC2025
ArticleKetamine

Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.

d'Andrea G, Cavallotto C, Pettorruso M +25

Europe PMC2025
ArticleKetamine

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Di Nicola M, Pepe M, d'Andrea G +26

Europe PMC2025
ArticleKetamine

Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.

d'Andrea G, Miuli A, Pettorruso M +12

Europe PMC2024
ArticleKetamine

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).

Pettorruso M, Guidotti R, d'Andrea G +25

Europe PMC2023
ArticleKetamine

Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.

Chiappini S, d'Andrea G, De Filippis S +10

Europe PMC2023
ArticleKetamine

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

Martinotti G, Dell'Osso B, Di Lorenzo G +23

Europe PMC2023